IMMUNOSCINTIGRAPHY OF PANCREATIC-CANCER WITH I-131-LABELED CA-19-9 AND ANTI - CEA ANTIBODIES

被引：0
|
作者：
LINDGREN, J
ROBERTS, P
HAGLUND, C
KAIRENTO, AL
LIEWENDAHL, K
机构：
[1] UNIV HELSINKI,DEPT BACTERIOL & IMMUNOL,SF-00100 HELSINKI 10,FINLAND
[2] UNIV HELSINKI,DEPT SURG 4,SF-00100 HELSINKI 10,FINLAND
[3] UNIV HELSINKI,CENT HOSP,CENT LAB,SF-00290 HELSINKI 29,FINLAND
来源：
TUMOUR BIOLOGY | 1986年 / 7卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：314 / 314
页数：1
相关论文
共 50 条
  • [11] 111-IN LABELED ANTI CA-19-9 ANTIBODIES IMMUNOSCINTIGRAPHY IN COLORECTAL-CARCINOMA-1ST RESULTS
    KOSTIC, K
    OBRADOVIC, V
    UGLJESIC, M
    ADANJAGRUJIC, G
    ARTIKO, V
    DAVIDOVIC, B
    PERIODICUM BIOLOGORUM, 1991, 93 (03) : 435 - 436
  • [12] SERUM CA-19-9 IN PANCREATIC-CANCER - A PROSPECTIVE-STUDY
    MALESCI, A
    SPINA, GP
    MARIANI, A
    MONTORSI, M
    TOMMASINI, MA
    BONATO, C
    BOCCHIA, P
    GASTROENTEROLOGY, 1987, 92 (05) : 1515 - 1515
  • [13] A JAPANESE PHASE-II STUDY OF IMMUNOSCINTIGRAPHY WITH I-131 ANTI CEA AND ANTI CA19-9 MONOCLONAL-ANTIBODIES
    INOUE, T
    SASAKI, Y
    ORIUCHI, N
    MITSUHASHI, N
    TSUJINO, D
    MAEHARA, T
    SUZUKI, Y
    BRITISH JOURNAL OF CANCER, 1989, 59 (02) : 310 - 310
  • [14] LOCALIZATION OF I-131-LABELED GOAT AND PRIMATE ANTI-CARCINOEMBRYONIC ANTIGEN (CEA) ANTIBODIES IN PATIENTS WITH CANCER
    SULLIVAN, DC
    SILVA, JS
    COX, CE
    HAAGENSEN, DE
    HARRIS, CC
    BRINER, WH
    WELLS, SA
    INVESTIGATIVE RADIOLOGY, 1981, 16 (05) : 367 - 367
  • [15] LOCALIZATION OF I-131-LABELED GOAT AND PRIMATE ANTI-CARCINOEMBRYONIC ANTIGEN (CEA) - ANTIBODIES IN PATIENTS WITH CANCER
    SULLIVAN, DC
    SILVA, JS
    COX, CE
    HAAGENSEN, DE
    HARRIS, CC
    BRINER, WH
    WELLS, SA
    INVESTIGATIVE RADIOLOGY, 1982, 17 (04) : 350 - 355
  • [16] CA-242, A NEW TUMOR-MARKER FOR PANCREATIC-CANCER - A COMPARISON WITH CA-19-9, CA-50 AND CEA
    HAGLUND, C
    LUNDIN, J
    KUUSELA, P
    ROBERTS, PJ
    BRITISH JOURNAL OF CANCER, 1994, 70 (03) : 487 - 492
  • [17] QUANTITATIVE-DETERMINATION OF UPTAKE OF I-131-LABELED ANTI-CEA AND CA 19-9 IN LIVER METASTASES USING SPECT
    LEINSINGER, G
    KIRSCH, CM
    KRAGH, P
    PLETZER, G
    LECHEL, U
    ANTIBODY IMMUNOCONJUGATES AND RADIOPHARMACEUTICALS, 1991, 4 (04): : 665 - 671
  • [18] THERAPY OF PANCREATIC CARCINOMAS (PACA) TRANSPLANTATION TUMORS WITH ANTI-CA19-9-I-131 AS WELL AS ANTI-CA19-9+ANTI-CEA-I-131
    KLAPDOR, R
    LANDER, S
    BAHLO, M
    MONTZ, R
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 1986, 24 (09): : 533 - 533
  • [19] IMMUNOSCINTIGRAPHY WITH MONOCLONAL ANTI-CEA OR ANTI-CEA/CA 19-9 ANTIBODIES IN THE GASTROINTESTINAL TUMORS
    CAMPIONI, P
    DERRICO, G
    RIFINI, V
    MAUSSIER, ML
    GARUFI, L
    CIARNIELLO, V
    BARONE, C
    JOURNAL OF NUCLEAR MEDICINE AND ALLIED SCIENCES, 1987, 31 (01): : 39 - 40
  • [20] SIGNIFICANCE OF IMMUNOSCINTIGRAPHY (IS) USING SPECT AND I-131 LABELED MONOCLONAL-ANTIBODIES (MAB) TO CEA/CA 19-9 IN THE FOLLOW-UP OF COLORECTAL-CANCER
    LEINSINGER, G
    SCHEIDHAUER, K
    DENECKE, H
    KRAGH, P
    HAAG, A
    MOSER, E
    KIRSCH, CM
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1988, 14 (5-6): : 223 - 223
12345